OCX Dividend History & Description — Oncocyte Corp
Oncocyte is a precision diagnostics company focused on developing and commercializing proprietary tests in three areas: DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies, VitaGraft is a blood-based solid organ transplantation monitoring test and DetermaCNI is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. When considering the Oncocyte Corp stock dividend history, we have taken known splits into account, such that the OCX dividend history is presented on a split-adjusted ("apples to apples") basis. Oncocyte Corp dividend history is presented both in graphical/chart form, and as a OCX dividend history data table along the right-hand column.